data_2mxh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mxh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 71.11 111.109 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -90.93 -11.61 38.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.11 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.78 -13.03 23.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 75.34 112.479 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.3 p-90 -70.04 -37.24 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.341 . . . . 75.42 110.9 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 -18.68 61.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.935 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.12 110.848 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -96.39 -77.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 7.1 m -106.37 132.4 20.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 53.04 110.93 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -7.98 22.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.691 2.261 . . . . 75.1 112.3 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 pp -75.01 -2.19 26.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 71.14 110.956 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.58 14.02 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -22.97 12.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 45.15 112.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -83.71 -59.62 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 73.11 110.913 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -93.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 52.43 112.5 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 75.42 112.461 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.736 0.303 . . . . 75.45 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.52 -24.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.97 -18.18 2.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 54.04 112.495 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 38.9 p-90 -55.24 -34.59 64.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 74.33 110.88 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -13.92 59.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.954 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -75.42 -76.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -93.29 -81.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 24.1 m -112.51 131.03 22.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.577 0.703 . . . . 71.02 110.884 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.75 -10.83 29.52 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.65 2.234 . . . . 74.4 112.335 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -9.29 52.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -79.34 57.13 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.885 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.17 -22.69 67.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 63.41 112.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.06 -26.97 5.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.43 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.14 -99.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 52.2 112.508 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.759 0.314 . . . . 70.35 111.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -21.31 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.4 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.38 -20.9 24.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 72.21 112.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 1.2 p-90 -62.89 -25.4 68.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 75.24 110.927 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -11.3 31.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.891 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -82.29 -81.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -98.57 -80.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.875 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -68.19 119.41 67.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.655 0.741 . . . . 70.32 110.904 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -11.92 31.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 73.22 112.389 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.67 24.79 9.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.943 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.55 55.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.42 25.59 19.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.799 -0.715 . . . . 51.01 112.496 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -119.84 -32.1 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 73.01 110.853 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.16 -88.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 74.02 112.521 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 72.04 112.504 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.813 0.34 . . . . 72.51 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -12.3 58.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.843 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.98 -13.22 18.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.779 -0.724 . . . . 52.42 112.483 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -69.86 -37.25 76.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 72.24 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -18.42 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.863 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -65.04 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.35 110.872 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -96.27 -77.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.897 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 59.3 m -107.31 131.97 21.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 60.23 110.878 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 -8.82 24.56 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.677 2.251 . . . . 70.12 112.317 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.33 -5.84 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.18 46.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.851 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.9 87.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.3 112.501 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -19.87 9.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.33 110.909 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.64 -97.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 70.4 112.486 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 74.12 112.515 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.813 0.339 . . . . 74.44 111.083 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.97 -12.89 29.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 74.03 110.868 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.12 15.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 71.43 112.515 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CE2' ' HG3' ' A' ' 6' ' ' LYS . 5.3 p-90 -57.43 -30.41 64.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 72.22 110.909 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 1.2 mtpm? -76.11 -13.7 60.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.874 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -71.49 -80.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 75.33 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -99.04 -79.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.916 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 25.8 p -101.59 131.58 22.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.608 0.718 . . . . 72.33 110.895 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.17 22.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 53.12 112.343 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pp -79.89 0.33 31.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.892 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -88.91 40.04 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.899 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 -13.42 83.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 75.44 112.485 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -98.55 -30.52 12.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 74.02 110.929 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.62 -95.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 72.4 112.512 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.764 -0.732 . . . . 50.43 112.481 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.797 0.332 . . . . 70.05 111.093 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -23.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.888 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.49 -14.88 22.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 74.12 112.483 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 5.6 p-90 -58.26 -40.01 80.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.845 0.355 . . . . 74.4 110.893 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -15.56 60.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 74.44 110.919 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.904 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -78.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 1.2 m -112.36 128.84 24.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.59 0.71 . . . . 73.42 110.906 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.74 -9.4 26.02 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 72.21 112.315 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.27 -11.75 44.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 9.4 m-85 -77.66 57.15 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 73.2 110.902 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.27 -24.22 67.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 62.14 112.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -28.25 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 74.21 110.907 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.83 -99.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 74.01 112.465 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 70.51 112.501 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.766 0.317 . . . . 71.41 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -12.95 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 71.34 110.885 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -61.13 -12.4 30.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 74.0 112.495 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.7 p-90 -67.51 -38.43 84.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.808 0.337 . . . . 65.53 110.886 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -22.21 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 72.54 110.923 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.2 mmt180 -60.84 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.51 110.838 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -96.0 -77.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.42 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 67.5 m -106.96 131.48 21.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.624 0.726 . . . . 62.11 110.91 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -8.58 23.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 73.52 112.356 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -4.96 29.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.43 110.886 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.884 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -12.18 69.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 73.3 112.47 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -115.71 -27.99 6.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 72.53 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.3 -89.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.02 112.499 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 74.33 112.499 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.815 0.34 . . . . 62.54 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -56.57 -21.71 28.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.878 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.01 -21.63 17.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 75.35 112.461 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER -66.93 -20.71 65.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 74.03 110.919 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 -13.69 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.892 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -79.08 -85.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 75.22 110.839 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -98.11 -77.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.44 110.91 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 19.2 m -65.25 114.02 13.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.617 0.722 . . . . 71.23 110.914 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.76 29.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 75.32 112.317 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.87 24.82 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.89 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.85 47.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 72.45 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.93 -43.47 73.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 70.4 112.527 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -31.83 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 73.23 110.91 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.72 -88.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 43.32 112.484 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 74.34 112.432 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.766 0.317 . . . . 71.12 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.03 -11.92 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 73.44 110.852 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.5 -12.62 26.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 71.4 112.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -68.84 -37.89 79.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 73.12 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 -19.83 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 64.42 110.851 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -63.45 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.858 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 -77.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 31.1 m -105.13 130.93 22.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 72.53 110.832 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -8.52 23.81 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.274 . . . . 74.43 112.35 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.83 -5.18 36.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 75.25 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.76 44.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.885 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.11 -14.0 83.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 61.1 112.491 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -29.74 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 73.55 110.862 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -89.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 74.04 112.536 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 64.44 112.483 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.798 0.332 . . . . 75.04 111.092 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.57 -11.62 60.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.15 110.838 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.98 -13.92 15.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 71.53 112.477 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.408 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.0 p-90 -71.65 -35.74 70.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 73.24 110.931 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -17.32 60.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.84 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -83.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 74.55 110.866 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -77.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 58.8 m -105.26 132.81 20.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.625 0.726 . . . . 75.32 110.907 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 73.42 112.381 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.11 -3.06 34.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.972 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.03 3.72 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.15 110.895 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.91 -29.0 13.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 72.41 112.485 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 -32.0 21.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 73.11 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.49 -97.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.12 112.499 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.707 -0.759 . . . . 72.12 112.465 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.782 0.325 . . . . 42.2 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -61.37 -56.33 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.44 110.891 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -25.02 6.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 44.54 112.547 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 3.7 m95 -96.52 -28.83 14.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 75.25 110.945 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -49.21 -38.41 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.51 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -58.08 -55.73 31.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.13 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.23 -75.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 115.03 32.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 71.44 110.884 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -17.07 37.84 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.711 2.274 . . . . 75.22 112.383 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.15 5.04 27.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.897 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.18 66.92 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.43 110.886 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.1 56.78 3.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 72.24 112.432 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -96.28 -75.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 73.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -111.78 3.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 74.21 112.49 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 51.54 112.471 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.796 0.331 . . . . 34.33 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -15.42 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.866 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.7 -13.97 27.08 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 72.34 112.435 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -63.66 -37.9 89.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.41 110.914 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -75.61 -14.31 60.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -73.08 -77.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.899 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -80.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.929 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -107.79 128.35 26.01 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.572 0.701 . . . . 75.12 110.842 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 -9.39 26.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.668 2.245 . . . . 70.13 112.324 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.32 -10.66 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.941 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 10.3 m-85 -78.32 56.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.43 -26.12 72.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 41.33 112.524 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -28.48 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 75.55 110.886 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.27 -96.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 71.23 112.455 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.516 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.793 0.33 . . . . 74.4 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -12.42 35.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.861 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.79 -12.39 27.95 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 64.33 112.478 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.4 p-90 -69.04 -38.94 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 64.03 110.907 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -71.27 -22.3 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.893 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -60.7 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.868 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -96.63 -77.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 74.55 110.908 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 69.6 m -105.58 131.61 21.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.621 0.724 . . . . 71.2 110.887 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.41 23.53 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.672 2.248 . . . . 75.43 112.359 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -76.19 -4.28 40.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 70.41 110.929 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.6 55.55 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.865 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.56 -30.74 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 72.13 112.453 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -63.54 -75.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 64.51 110.937 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 60.34 112.519 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 54.41 112.48 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.764 0.316 . . . . 75.54 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -53.77 54.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 73.11 110.868 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.09 -23.42 11.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 54.02 112.495 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.417 ' HE1' ' N ' ' A' ' 16' ' ' GLY . 3.6 m95 -95.74 -32.03 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.35 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -46.12 -46.5 17.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.886 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -45.35 -56.8 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 73.33 110.872 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -90.47 -76.04 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 74.12 110.908 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -120.49 102.44 45.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.631 0.729 . . . . 73.45 110.917 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 9' ' ' CYS . 53.6 Cg_endo -69.81 -13.86 35.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 73.34 112.342 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -5.81 38.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.89 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -93.47 69.52 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 71.32 110.863 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.36 58.85 2.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 73.11 112.519 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -101.86 -73.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 74.52 110.92 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 -112.19 3.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 65.34 112.47 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.417 ' N ' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 63.21 112.481 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.806 0.336 . . . . 74.02 111.1 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -10.13 22.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.864 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.51 -11.82 4.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.799 -0.715 . . . . 62.02 112.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.6 m95 -37.12 -77.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.801 0.334 . . . . 73.44 110.887 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -66.16 -30.56 71.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.91 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.516 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 13.2 mtp180 -55.53 -78.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.9 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -96.61 -78.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 75.35 110.859 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.81 130.14 24.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 74.41 110.947 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -4.96 15.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 74.33 112.341 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.78 10.09 24.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.894 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.62 39.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 72.54 110.897 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.42 -21.63 57.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 61.32 112.463 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -31.98 72.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 71.34 110.852 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.68 -92.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 63.34 112.491 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 73.31 112.482 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 71.24 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -99.96 -16.84 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.856 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.37 -13.28 3.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 71.42 112.505 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 21.8 m95 -41.85 -76.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 75.33 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -76.39 -14.92 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 74.23 110.896 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -79.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.55 110.865 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -93.06 -75.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.915 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.47 128.74 25.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.709 . . . . 64.23 110.87 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -5.31 15.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 74.15 112.376 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.96 10.49 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.937 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -94.44 63.46 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.34 110.866 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.61 20.43 41.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 75.31 112.456 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 -19.69 8.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 64.4 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.18 -76.44 0.58 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 63.23 112.46 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 64.53 112.472 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.799 0.333 . . . . 64.5 111.087 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -9.84 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.38 -12.07 4.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 50.43 112.536 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m95 -36.56 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 74.43 110.943 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -30.76 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.4 mtp180 -55.26 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.877 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -96.59 -78.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.9 130.12 24.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.623 0.725 . . . . 75.5 110.898 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -4.5 14.19 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.667 2.245 . . . . 73.15 112.282 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.69 3.52 31.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 75.13 110.961 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -88.84 60.87 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.97 6.05 76.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 64.3 112.508 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -29.82 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.43 110.881 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.89 -89.11 1.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.13 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 75.13 112.466 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.756 0.313 . . . . 75.33 111.099 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -12.57 58.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.866 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.95 -12.98 17.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 72.51 112.452 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -70.23 -37.49 75.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 74.45 110.931 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -18.19 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.34 110.884 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -65.28 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 64.44 110.884 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -77.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.878 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 18.8 p -104.45 130.73 22.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 71.45 110.831 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -9.91 27.26 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.699 2.266 . . . . 75.23 112.318 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.13 -4.02 36.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 75.22 110.939 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 56.34 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.17 27.0 11.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 72.13 112.527 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.12 -68.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 71.53 110.859 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.92 -103.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 73.04 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 70.45 112.451 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.768 0.318 . . . . 43.25 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -13.62 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 74.13 110.878 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.6 -19.03 17.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 44.42 112.513 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.442 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -80.11 -17.66 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 74.13 110.969 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 47.0 mmtt -78.41 -14.76 59.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.904 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -85.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.33 110.851 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -80.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.51 110.932 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -53.55 109.12 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 71.5 110.931 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -12.74 33.47 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.663 2.242 . . . . 75.21 112.336 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.12 25.54 9.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.922 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 4.56 14.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 72.21 110.886 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.91 -30.13 6.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 51.55 112.486 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -40.8 95.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 74.13 110.895 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.83 -96.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 63.52 112.474 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 72.22 112.499 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.847 0.356 . . . . 72.41 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -13.87 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.826 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.42 18.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 61.24 112.49 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -76.8 -14.09 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.2 110.935 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -86.54 -14.04 44.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.892 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -78.92 -82.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.04 110.876 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.25 -80.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.883 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 20.2 m -62.45 112.19 6.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 64.45 110.894 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -10.54 28.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 71.1 112.368 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 25.03 10.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.914 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -80.08 8.25 7.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 75.13 110.848 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.06 -29.4 8.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.5 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 74.41 110.916 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 -92.38 1.82 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 73.25 112.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 72.34 112.525 -179.892 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.854 0.359 . . . . 71.12 111.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.45 74.01 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 71.11 111.109 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -90.93 -11.61 38.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.11 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.78 -13.03 23.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 75.34 112.479 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.3 p-90 -70.04 -37.24 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.341 . . . . 75.42 110.9 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 -18.68 61.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.935 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.12 110.848 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -96.39 -77.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 7.1 m -106.37 132.4 20.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 53.04 110.93 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -7.98 22.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.691 2.261 . . . . 75.1 112.3 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 pp -75.01 -2.19 26.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 71.14 110.956 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.58 14.02 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -22.97 12.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 45.15 112.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -83.71 -59.62 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 73.11 110.913 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -93.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 52.43 112.5 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 75.42 112.461 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.807 0.337 . . . . 75.21 111.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.02 43.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.45 111.093 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.52 -24.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.97 -18.18 2.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 54.04 112.495 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 38.9 p-90 -55.24 -34.59 64.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 74.33 110.88 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -13.92 59.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.954 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -75.42 -76.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.13 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -93.29 -81.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 24.1 m -112.51 131.03 22.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.577 0.703 . . . . 71.02 110.884 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.427 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.75 -10.83 29.52 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.65 2.234 . . . . 74.4 112.335 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -9.29 52.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.0 110.903 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -79.34 57.13 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.885 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.17 -22.69 67.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 63.41 112.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.06 -26.97 5.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.43 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.14 -99.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 52.2 112.508 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.867 0.365 . . . . 74.24 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.98 55.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 70.35 111.094 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -21.31 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.4 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.38 -20.9 24.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 72.21 112.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 1.2 p-90 -62.89 -25.4 68.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 75.24 110.927 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -11.3 31.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.891 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -82.29 -81.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -98.57 -80.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.875 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -68.19 119.41 67.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.655 0.741 . . . . 70.32 110.904 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -11.92 31.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 73.22 112.389 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.67 24.79 9.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.943 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.55 55.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.42 25.59 19.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.799 -0.715 . . . . 51.01 112.496 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -119.84 -32.1 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 73.01 110.853 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.16 -88.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 74.02 112.521 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 72.04 112.504 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.887 0.375 . . . . 75.44 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.61 64.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.51 111.114 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -12.3 58.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.843 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.98 -13.22 18.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.779 -0.724 . . . . 52.42 112.483 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -69.86 -37.25 76.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 72.24 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -18.42 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.863 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -65.04 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.35 110.872 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -96.27 -77.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.897 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 59.3 m -107.31 131.97 21.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 60.23 110.878 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 -8.82 24.56 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.677 2.251 . . . . 70.12 112.317 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.33 -5.84 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.18 46.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.851 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.9 87.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.3 112.501 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -19.87 9.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.33 110.909 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.64 -97.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 70.4 112.486 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 74.12 112.515 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.857 0.36 . . . . 64.11 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.25 73.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.083 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.97 -12.89 29.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 74.03 110.868 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.12 15.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 71.43 112.515 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CE2' ' HG3' ' A' ' 6' ' ' LYS . 5.3 p-90 -57.43 -30.41 64.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 72.22 110.909 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 1.2 mtpm? -76.11 -13.7 60.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.874 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -71.49 -80.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 75.33 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -99.04 -79.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.916 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 25.8 p -101.59 131.58 22.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.608 0.718 . . . . 72.33 110.895 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.17 22.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 53.12 112.343 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 pp -79.89 0.33 31.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.892 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -88.91 40.04 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.899 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 -13.42 83.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 75.44 112.485 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -98.55 -30.52 12.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 74.02 110.929 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.62 -95.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 72.4 112.512 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.764 -0.732 . . . . 50.43 112.481 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 74.04 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.62 71.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 70.05 111.093 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -23.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.888 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.49 -14.88 22.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 74.12 112.483 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 5.6 p-90 -58.26 -40.01 80.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.845 0.355 . . . . 74.4 110.893 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -15.56 60.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 74.44 110.919 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.904 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -78.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 1.2 m -112.36 128.84 24.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.59 0.71 . . . . 73.42 110.906 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.74 -9.4 26.02 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 72.21 112.315 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.27 -11.75 44.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 9.4 m-85 -77.66 57.15 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 73.2 110.902 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.27 -24.22 67.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 62.14 112.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -28.25 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 74.21 110.907 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.83 -99.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 74.01 112.465 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 70.51 112.501 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.865 0.364 . . . . 71.03 111.133 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.06 72.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.41 111.108 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -12.95 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 71.34 110.885 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -61.13 -12.4 30.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 74.0 112.495 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.7 p-90 -67.51 -38.43 84.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.808 0.337 . . . . 65.53 110.886 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -22.21 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 72.54 110.923 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.2 mmt180 -60.84 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.51 110.838 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -96.0 -77.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.42 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 67.5 m -106.96 131.48 21.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.624 0.726 . . . . 62.11 110.91 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -8.58 23.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 73.52 112.356 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.57 -4.96 29.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.43 110.886 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.884 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -12.18 69.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 73.3 112.47 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -115.71 -27.99 6.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 72.53 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.3 -89.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.02 112.499 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 74.33 112.499 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.826 0.346 . . . . 75.14 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.76 57.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.54 111.14 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -56.57 -21.71 28.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.878 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.01 -21.63 17.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 75.35 112.461 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.507 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER -66.93 -20.71 65.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 74.03 110.919 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 -13.69 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.892 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -79.08 -85.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 75.22 110.839 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -98.11 -77.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.44 110.91 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 19.2 m -65.25 114.02 13.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.617 0.722 . . . . 71.23 110.914 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -10.76 29.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 75.32 112.317 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.87 24.82 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.89 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.85 47.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 72.45 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.93 -43.47 73.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 70.4 112.527 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -31.83 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 73.23 110.91 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.72 -88.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 43.32 112.484 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 74.34 112.432 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.852 0.358 . . . . 74.05 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.08 72.54 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 71.12 111.112 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.03 -11.92 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 73.44 110.852 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.5 -12.62 26.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 71.4 112.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -68.84 -37.89 79.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 73.12 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 -19.83 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 64.42 110.851 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -63.45 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.858 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 -77.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 31.1 m -105.13 130.93 22.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 72.53 110.832 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -8.52 23.81 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.274 . . . . 74.43 112.35 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.83 -5.18 36.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 75.25 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.76 44.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.885 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.11 -14.0 83.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 61.1 112.491 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -29.74 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 73.55 110.862 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -89.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 74.04 112.536 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 64.44 112.483 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.819 0.342 . . . . 73.52 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.29 66.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 75.04 111.092 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.57 -11.62 60.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.15 110.838 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.98 -13.92 15.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 71.53 112.477 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.408 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.0 p-90 -71.65 -35.74 70.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 73.24 110.931 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -17.32 60.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.84 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -83.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 74.55 110.866 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -77.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 58.8 m -105.26 132.81 20.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.625 0.726 . . . . 75.32 110.907 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 73.42 112.381 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 pp -76.11 -3.06 34.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.972 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.03 3.72 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.15 110.895 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.91 -29.0 13.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 72.41 112.485 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 -32.0 21.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 73.11 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.49 -97.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.12 112.499 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.707 -0.759 . . . . 72.12 112.465 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.778 0.323 . . . . 65.22 111.128 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.05 68.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 42.2 111.1 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -61.37 -56.33 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.44 110.891 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -25.02 6.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 44.54 112.547 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 3.7 m95 -96.52 -28.83 14.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 75.25 110.945 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -49.21 -38.41 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.51 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -58.08 -55.73 31.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.13 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.23 -75.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 115.03 32.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 71.44 110.884 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -17.07 37.84 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.711 2.274 . . . . 75.22 112.383 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.15 5.04 27.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.897 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.18 66.92 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.43 110.886 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.1 56.78 3.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 72.24 112.432 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -96.28 -75.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 73.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -111.78 3.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 74.21 112.49 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 51.54 112.471 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.805 0.336 . . . . 64.21 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.15 61.98 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 34.33 111.139 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -15.42 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.866 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.7 -13.97 27.08 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 72.34 112.435 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -63.66 -37.9 89.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.41 110.914 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -75.61 -14.31 60.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -73.08 -77.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.899 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -80.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.929 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -107.79 128.35 26.01 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.572 0.701 . . . . 75.12 110.842 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 -9.39 26.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.668 2.245 . . . . 70.13 112.324 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.32 -10.66 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.941 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 10.3 m-85 -78.32 56.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.43 -26.12 72.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 41.33 112.524 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -28.48 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 75.55 110.886 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.27 -96.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 71.23 112.455 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 73.33 112.516 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.338 . . . . 63.41 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.16 72.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.139 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -12.42 35.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.861 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.79 -12.39 27.95 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 64.33 112.478 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.4 p-90 -69.04 -38.94 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 64.03 110.907 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -71.27 -22.3 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 75.21 110.893 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -60.7 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.868 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -96.63 -77.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 74.55 110.908 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 69.6 m -105.58 131.61 21.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.621 0.724 . . . . 71.2 110.887 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.41 23.53 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.672 2.248 . . . . 75.43 112.359 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -76.19 -4.28 40.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 70.41 110.929 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.6 55.55 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.865 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.56 -30.74 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 72.13 112.453 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -63.54 -75.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 64.51 110.937 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 60.34 112.519 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 54.41 112.48 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.806 0.336 . . . . 74.1 111.147 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.98 63.4 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 75.54 111.118 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -53.77 54.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 73.11 110.868 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.09 -23.42 11.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 54.02 112.495 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.417 ' HE1' ' N ' ' A' ' 16' ' ' GLY . 3.6 m95 -95.74 -32.03 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 73.35 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -46.12 -46.5 17.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.886 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -45.35 -56.8 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 73.33 110.872 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -90.47 -76.04 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 74.12 110.908 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -120.49 102.44 45.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.631 0.729 . . . . 73.45 110.917 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 9' ' ' CYS . 53.6 Cg_endo -69.81 -13.86 35.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 73.34 112.342 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -5.81 38.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.89 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -93.47 69.52 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 71.32 110.863 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.36 58.85 2.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 73.11 112.519 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -101.86 -73.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 74.52 110.92 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 -112.19 3.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 65.34 112.47 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' N ' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 63.21 112.481 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 73.14 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.77 75.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.02 111.1 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -10.13 22.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.864 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.51 -11.82 4.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.799 -0.715 . . . . 62.02 112.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.6 m95 -37.12 -77.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.801 0.334 . . . . 73.44 110.887 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -66.16 -30.56 71.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.91 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.516 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 13.2 mtp180 -55.53 -78.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.12 110.9 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -96.61 -78.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 75.35 110.859 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.81 130.14 24.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 74.41 110.947 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -4.96 15.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 74.33 112.341 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.78 10.09 24.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.894 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.62 39.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 72.54 110.897 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.42 -21.63 57.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 61.32 112.463 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -31.98 72.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 71.34 110.852 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.68 -92.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 63.34 112.491 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 73.31 112.482 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.854 0.359 . . . . 74.52 111.106 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.61 74.79 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.24 111.103 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -99.96 -16.84 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.856 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.37 -13.28 3.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 71.42 112.505 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 21.8 m95 -41.85 -76.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 75.33 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -76.39 -14.92 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 74.23 110.896 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -79.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.55 110.865 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -93.06 -75.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.915 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.47 128.74 25.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.709 . . . . 64.23 110.87 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -5.31 15.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 74.15 112.376 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.96 10.49 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.937 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -94.44 63.46 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.34 110.866 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.61 20.43 41.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 75.31 112.456 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 -19.69 8.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 64.4 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.18 -76.44 0.58 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 63.23 112.46 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 64.53 112.472 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.847 0.356 . . . . 75.31 111.097 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.88 75.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 64.5 111.087 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -9.84 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.38 -12.07 4.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 50.43 112.536 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m95 -36.56 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 74.43 110.943 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -30.76 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.4 mtp180 -55.26 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.877 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -96.59 -78.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.9 130.12 24.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.623 0.725 . . . . 75.5 110.898 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -4.5 14.19 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.667 2.245 . . . . 73.15 112.282 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -104.69 3.52 31.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 75.13 110.961 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -88.84 60.87 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.97 6.05 76.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 64.3 112.508 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -29.82 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.43 110.881 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.89 -89.11 1.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.13 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 75.13 112.466 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.846 0.355 . . . . 74.34 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.32 59.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 75.33 111.099 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -12.57 58.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.866 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.95 -12.98 17.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 72.51 112.452 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -70.23 -37.49 75.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 74.45 110.931 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -18.19 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.34 110.884 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -65.28 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 64.44 110.884 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -77.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.878 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 18.8 p -104.45 130.73 22.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 71.45 110.831 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -9.91 27.26 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.699 2.266 . . . . 75.23 112.318 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.13 -4.02 36.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 75.22 110.939 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 56.34 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.17 27.0 11.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 72.13 112.527 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.12 -68.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 71.53 110.859 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.92 -103.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 73.04 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 70.45 112.451 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.807 0.337 . . . . 62.22 111.099 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.75 51.29 2.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 43.25 111.068 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -13.62 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 74.13 110.878 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.6 -19.03 17.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 44.42 112.513 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.442 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -80.11 -17.66 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 74.13 110.969 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 47.0 mmtt -78.41 -14.76 59.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.904 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -85.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.33 110.851 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -80.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.51 110.932 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -53.55 109.12 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 71.5 110.931 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -12.74 33.47 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.663 2.242 . . . . 75.21 112.336 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.12 25.54 9.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.922 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 4.56 14.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 72.21 110.886 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.91 -30.13 6.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 51.55 112.486 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -40.8 95.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 74.13 110.895 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.83 -96.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 63.52 112.474 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 72.22 112.499 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.808 0.337 . . . . 63.14 111.13 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.86 54.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.41 111.131 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -13.87 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.826 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.42 18.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 61.24 112.49 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -76.8 -14.09 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 74.2 110.935 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -86.54 -14.04 44.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.892 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -78.92 -82.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.04 110.876 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.25 -80.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.883 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 20.2 m -62.45 112.19 6.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 64.45 110.894 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -10.54 28.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 71.1 112.368 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.51 25.03 10.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.914 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -80.08 8.25 7.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 75.13 110.848 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.06 -29.4 8.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.5 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 74.41 110.916 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 -92.38 1.82 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 73.25 112.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 72.34 112.525 -179.892 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 41.140000000000001 111.109 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -90.93 -11.61 38.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.109999999999999 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.78 -13.03 23.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 75.340000000000003 112.479 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.3 p-90 -70.04 -37.24 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.341 . . . . 74.239999999999995 110.9 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 -18.68 61.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 110.935 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.120000000000005 110.848 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -96.39 -77.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 7.1 m -106.37 132.4 20.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 53.039999999999999 110.93 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.79 -7.98 22.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.691 2.261 . . . . 75.099999999999994 112.3 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.4 pp -75.01 -2.19 26.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 50.299999999999997 110.956 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.58 14.02 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.439999999999998 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -22.97 12.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 45.149999999999999 112.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -83.71 -59.62 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 73.109999999999999 110.913 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -93.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 44.109999999999999 112.5 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 75.420000000000002 112.461 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.736 0.303 . . . . 75.450000000000003 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.52 -24.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.97 -18.18 2.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 54.039999999999999 112.495 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 38.9 p-90 -55.24 -34.59 64.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 74.329999999999998 110.88 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -13.92 59.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 72.409999999999997 110.954 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -75.42 -76.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.230000000000004 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -93.29 -81.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 24.1 m -112.51 131.03 22.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.577 0.703 . . . . 71.019999999999996 110.884 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.75 -10.83 29.52 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.65 2.234 . . . . 62.210000000000001 112.335 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -9.29 52.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.200000000000003 110.903 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -79.34 57.13 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 64.150000000000006 110.885 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.17 -22.69 67.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 63.409999999999997 112.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.06 -26.97 5.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.14 -99.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.67 -0.776 . . . . 73.439999999999998 112.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 52.200000000000003 112.508 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.759 0.314 . . . . 70.349999999999994 111.094 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -21.31 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.400000000000006 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.38 -20.9 24.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 72.209999999999994 112.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.518 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 1.2 p-90 -62.89 -25.4 68.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 64.239999999999995 110.927 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -11.3 31.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 50.009999999999998 110.891 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -82.29 -81.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.099999999999994 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -98.57 -80.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.120000000000005 110.875 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -68.19 119.41 67.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.655 0.741 . . . . 70.319999999999993 110.904 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.628 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.2 Cg_endo -69.7 -11.92 31.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 73.219999999999999 112.389 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.67 24.79 9.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.943 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.55 55.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.42 25.59 19.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.799 -0.715 . . . . 51.009999999999998 112.496 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -119.84 -32.1 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 73.010000000000005 110.853 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.16 -88.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 74.019999999999996 112.521 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 51.439999999999998 112.504 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.813 0.34 . . . . 62.32 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -12.3 58.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.843 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.98 -13.22 18.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.779 -0.724 . . . . 52.420000000000002 112.483 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -69.86 -37.25 76.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 72.239999999999995 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -18.42 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 72.030000000000001 110.863 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -65.04 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 73.219999999999999 110.872 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -96.27 -77.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 110.897 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 59.3 m -107.31 131.97 21.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 43.149999999999999 110.878 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 -8.82 24.56 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.677 2.251 . . . . 70.120000000000005 112.317 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.33 -5.84 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.18 46.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.851 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.9 87.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.299999999999997 112.501 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -19.87 9.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 64.329999999999998 110.909 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.64 -97.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 70.400000000000006 112.486 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 54.109999999999999 112.515 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.813 0.339 . . . . 74.439999999999998 111.083 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.97 -12.89 29.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 54.340000000000003 110.868 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.12 15.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 63.450000000000003 112.515 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.489 ' CE2' ' HG3' ' A' ' 6' ' ' LYS . 5.3 p-90 -57.43 -30.41 64.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 72.150000000000006 110.909 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 1.2 mtpm? -76.11 -13.7 60.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 110.874 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -71.49 -80.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -99.04 -79.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 74.549999999999997 110.916 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 25.8 p -101.59 131.58 22.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.608 0.718 . . . . 71.530000000000001 110.895 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.76 -8.17 22.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 51.119999999999997 112.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.1 pp -79.89 0.33 31.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 72.019999999999996 110.892 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -88.91 40.04 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.540000000000006 110.899 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 -13.42 83.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -98.55 -30.52 12.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 74.019999999999996 110.929 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.62 -95.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 72.400000000000006 112.512 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.764 -0.732 . . . . 50.43 112.481 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 12' ' ' PHE . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.797 0.332 . . . . 70.049999999999997 111.093 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -23.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 64.319999999999993 110.888 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.49 -14.88 22.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 73.239999999999995 112.483 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 12' ' ' PHE . 5.6 p-90 -58.26 -40.01 80.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.845 0.355 . . . . 73.109999999999999 110.893 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -15.56 60.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 63.530000000000001 110.919 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.904 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -78.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.150000000000006 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 1.2 m -112.36 128.84 24.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.59 0.71 . . . . 73.420000000000002 110.906 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.4 26.02 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 72.209999999999994 112.315 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.27 -11.75 44.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.019999999999996 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 9.4 m-85 -77.66 57.15 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 62.109999999999999 110.902 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.27 -24.22 67.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 44.409999999999997 112.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -28.25 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 74.209999999999994 110.907 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.83 -99.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 74.010000000000005 112.465 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 70.510000000000005 112.501 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.766 0.317 . . . . 71.019999999999996 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -12.95 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 71.230000000000004 110.885 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -61.13 -12.4 30.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 41.200000000000003 112.495 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.7 p-90 -67.51 -38.43 84.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.808 0.337 . . . . 65.530000000000001 110.886 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -22.21 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 64.010000000000005 110.923 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.2 mmt180 -60.84 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.838 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -96.0 -77.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.420000000000002 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 67.5 m -106.96 131.48 21.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.624 0.726 . . . . 62.109999999999999 110.91 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 -8.58 23.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 73.519999999999996 112.356 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.7 pp -71.57 -4.96 29.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 110.886 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 63.340000000000003 110.884 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -12.18 69.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 71.329999999999998 112.47 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -115.71 -27.99 6.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 72.120000000000005 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.3 -89.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.019999999999996 112.499 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.499 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.815 0.34 . . . . 62.539999999999999 111.14 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -56.57 -21.71 28.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.878 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.01 -21.63 17.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 75.349999999999994 112.461 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER -66.93 -20.71 65.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 74.030000000000001 110.919 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 -13.69 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 72.439999999999998 110.892 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -79.08 -85.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 75.219999999999999 110.839 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -98.11 -77.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.91 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 19.2 m -65.25 114.02 13.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.617 0.722 . . . . 71.230000000000004 110.914 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.661 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.4 Cg_endo -69.79 -10.76 29.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.129999999999995 112.317 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.87 24.82 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.200000000000003 110.89 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.85 47.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 72.450000000000003 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.93 -43.47 73.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 70.400000000000006 112.527 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -31.83 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 61.420000000000002 110.91 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.72 -88.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 43.32 112.484 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 74.340000000000003 112.432 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.766 0.317 . . . . 64.230000000000004 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.03 -11.92 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 73.439999999999998 110.852 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -60.5 -12.62 26.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 71.400000000000006 112.479 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -68.84 -37.89 79.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 73.120000000000005 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 -19.83 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 54.119999999999997 110.851 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.3 mmt180 -63.45 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.420000000000002 110.858 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 -77.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 63.520000000000003 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 31.1 m -105.13 130.93 22.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 71.549999999999997 110.832 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.81 -8.52 23.81 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.274 . . . . 74.430000000000007 112.35 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.83 -5.18 36.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 75.25 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.76 44.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 110.885 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.11 -14.0 83.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 54.130000000000003 112.491 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -29.74 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 73.549999999999997 110.862 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -89.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 74.040000000000006 112.536 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 64.439999999999998 112.483 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.798 0.332 . . . . 75.040000000000006 111.092 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.57 -11.62 60.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.150000000000006 110.838 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.98 -13.92 15.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 61.200000000000003 112.477 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.0 p-90 -71.65 -35.74 70.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 62.119999999999997 110.931 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -17.32 60.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 74.209999999999994 110.84 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -83.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 55.509999999999998 110.866 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -77.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 58.8 m -105.26 132.81 20.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.625 0.726 . . . . 75.319999999999993 110.907 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.75 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 64.030000000000001 112.381 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.3 pp -76.11 -3.06 34.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.972 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.03 3.72 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 110.895 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.91 -29.0 13.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 61.009999999999998 112.485 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 -32.0 21.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 73.109999999999999 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.49 -97.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 63.439999999999998 112.499 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.707 -0.759 . . . . 72.120000000000005 112.465 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.782 0.325 . . . . 32.509999999999998 111.1 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -61.37 -56.33 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.439999999999998 110.891 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -25.02 6.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 44.539999999999999 112.547 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.509 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.7 m95 -96.52 -28.83 14.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 75.25 110.945 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -49.21 -38.41 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.150000000000006 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -58.08 -55.73 31.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.129999999999995 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.23 -75.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 115.03 32.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 71.439999999999998 110.884 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -17.07 37.84 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.711 2.274 . . . . 75.219999999999999 112.383 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -84.15 5.04 27.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.897 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.18 66.92 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 110.886 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -77.1 56.78 3.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 72.239999999999995 112.432 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -96.28 -75.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 73.430000000000007 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -111.78 3.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 74.209999999999994 112.49 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 51.539999999999999 112.471 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.796 0.331 . . . . 34.329999999999998 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -15.42 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 110.866 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.7 -13.97 27.08 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 70.5 112.435 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 4.6 p-90 -63.66 -37.9 89.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 110.914 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -75.61 -14.31 60.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -73.08 -77.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 64.519999999999996 110.899 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -80.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 63.200000000000003 110.929 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -107.79 128.35 26.01 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.572 0.701 . . . . 75.120000000000005 110.842 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 -9.39 26.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.668 2.245 . . . . 70.129999999999995 112.324 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.6 pp -67.32 -10.66 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.941 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 10.3 m-85 -78.32 56.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.891 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.43 -26.12 72.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 41.329999999999998 112.524 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -28.48 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 71.049999999999997 110.886 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.27 -96.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 41.350000000000001 112.455 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 73.310000000000002 112.516 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.793 0.33 . . . . 74.400000000000006 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -12.42 35.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 75.310000000000002 110.861 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.79 -12.39 27.95 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 63.310000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.4 p-90 -69.04 -38.94 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 54.229999999999997 110.907 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -71.27 -22.3 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 110.893 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -60.7 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 110.868 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -96.63 -77.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.349999999999994 110.908 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 69.6 m -105.58 131.61 21.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.621 0.724 . . . . 55.340000000000003 110.887 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.76 -8.41 23.53 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.672 2.248 . . . . 73.409999999999997 112.359 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -76.19 -4.28 40.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 61.310000000000002 110.929 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.6 55.55 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.865 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.56 -30.74 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 72.129999999999995 112.453 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -63.54 -75.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 52.119999999999997 110.937 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 60.340000000000003 112.519 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 54.409999999999997 112.48 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.764 0.316 . . . . 64.340000000000003 111.118 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -53.77 54.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 62.020000000000003 110.868 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.09 -23.42 11.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 35.130000000000003 112.495 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.684 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.6 m95 -95.74 -32.03 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 72.5 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -46.12 -46.5 17.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.200000000000003 110.886 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -45.35 -56.8 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 73.329999999999998 110.872 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -90.47 -76.04 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 64.400000000000006 110.908 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -120.49 102.44 45.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.631 0.729 . . . . 73.450000000000003 110.917 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 9' ' ' CYS . 53.6 Cg_endo -69.81 -13.86 35.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 61.020000000000003 112.342 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -5.81 38.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.89 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -93.47 69.52 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 65.349999999999994 110.863 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -74.36 58.85 2.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 73.109999999999999 112.519 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -101.86 -73.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 74.519999999999996 110.92 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 -112.19 3.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 65.340000000000003 112.47 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' N ' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 63.210000000000001 112.481 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.806 0.336 . . . . 72.109999999999999 111.1 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -10.13 22.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.864 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.51 -11.82 4.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.799 -0.715 . . . . 40.509999999999998 112.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.6 m95 -37.12 -77.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.801 0.334 . . . . 73.030000000000001 110.887 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -66.16 -30.56 71.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.230000000000004 110.91 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 13.2 mtp180 -55.53 -78.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.319999999999993 110.9 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -96.61 -78.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.400000000000006 110.859 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -121.81 130.14 24.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 73.25 110.947 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -4.96 15.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 65.329999999999998 112.341 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.78 10.09 24.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.894 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.62 39.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 61.130000000000003 110.897 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.42 -21.63 57.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 61.32 112.463 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -31.98 72.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 44.25 110.852 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.68 -92.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 54.25 112.491 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 73.310000000000002 112.482 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HB1' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 71.219999999999999 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -99.96 -16.84 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.409999999999997 110.856 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.37 -13.28 3.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 71.420000000000002 112.505 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 2' ' ' ALA . 21.8 m95 -41.85 -76.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 75.329999999999998 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -76.39 -14.92 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 71.209999999999994 110.896 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -79.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.549999999999997 110.865 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -93.06 -75.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.915 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.47 128.74 25.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.709 . . . . 62.299999999999997 110.87 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.5 Cg_endo -69.72 -5.31 15.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 74.150000000000006 112.376 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.55 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -110.96 10.49 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 61.049999999999997 110.937 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -94.44 63.46 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.120000000000005 110.866 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.61 20.43 41.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 75.310000000000002 112.456 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 -19.69 8.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 64.310000000000002 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.18 -76.44 0.58 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 53.240000000000002 112.46 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 64.530000000000001 112.472 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.799 0.333 . . . . 64.5 111.087 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -9.84 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.540000000000006 110.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.38 -12.07 4.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 50.409999999999997 112.536 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m95 -36.56 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 61.130000000000003 110.943 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -30.76 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 74.400000000000006 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.529 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.4 mtp180 -55.26 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.530000000000001 110.877 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -96.59 -78.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 64.439999999999998 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.9 130.12 24.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.623 0.725 . . . . 74.430000000000007 110.898 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 53.4 Cg_endo -69.82 -4.5 14.19 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.667 2.245 . . . . 73.150000000000006 112.282 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.9 pp -104.69 3.52 31.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 74.120000000000005 110.961 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -88.84 60.87 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 74.400000000000006 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.97 6.05 76.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 64.299999999999997 112.508 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -29.82 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 70.299999999999997 110.881 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.89 -89.11 1.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.129999999999995 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 75.129999999999995 112.466 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.756 0.313 . . . . 73.319999999999993 111.099 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -12.57 58.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.239999999999995 110.866 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.95 -12.98 17.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 72.510000000000005 112.452 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -70.23 -37.49 75.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 71.400000000000006 110.931 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -18.19 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 64.340000000000003 110.884 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -65.28 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 110.884 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -77.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 110.878 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 18.8 p -104.45 130.73 22.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 71.450000000000003 110.831 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 -9.91 27.26 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.699 2.266 . . . . 74.329999999999998 112.318 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.13 -4.02 36.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 71.409999999999997 110.939 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 56.34 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.17 27.0 11.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 72.129999999999995 112.527 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.12 -68.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 71.530000000000001 110.859 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.92 -103.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 73.040000000000006 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 70.450000000000003 112.451 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.768 0.318 . . . . 43.25 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -13.62 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 74.129999999999995 110.878 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.6 -19.03 17.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 44.420000000000002 112.513 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -80.11 -17.66 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 62.530000000000001 110.969 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 47.0 mmtt -78.41 -14.76 59.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.209999999999994 110.904 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -85.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 74.150000000000006 110.851 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -80.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.932 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -53.55 109.12 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 71.5 110.931 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.5 Cg_endo -69.78 -12.74 33.47 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.663 2.242 . . . . 61.420000000000002 112.336 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.12 25.54 9.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.239999999999995 110.922 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 4.56 14.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 72.209999999999994 110.886 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.91 -30.13 6.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 42.100000000000001 112.486 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -40.8 95.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 62.229999999999997 110.895 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.83 -96.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 63.520000000000003 112.474 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 72.219999999999999 112.499 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' HA2' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.847 0.356 . . . . 70.549999999999997 111.131 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -13.87 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 110.826 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.42 18.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 60.219999999999999 112.49 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -76.8 -14.09 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 61.200000000000003 110.935 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -86.54 -14.04 44.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.892 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -78.92 -82.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.319999999999993 110.876 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.25 -80.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 110.883 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 20.2 m -62.45 112.19 6.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 64.450000000000003 110.894 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.556 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.4 Cg_endo -69.72 -10.54 28.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 62.350000000000001 112.368 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -120.51 25.03 10.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.914 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -80.08 8.25 7.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 71.439999999999998 110.848 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.06 -29.4 8.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 72.439999999999998 112.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.5 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 61.109999999999999 110.916 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 -92.38 1.82 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 54.310000000000002 112.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 64.010000000000005 112.525 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.854 0.359 . . . . 71.120000000000005 111.113 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.45 74.01 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 41.140000000000001 111.109 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -90.93 -11.61 38.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.109999999999999 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.78 -13.03 23.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 75.340000000000003 112.479 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.3 p-90 -70.04 -37.24 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.341 . . . . 74.239999999999995 110.9 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 -18.68 61.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 110.935 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.120000000000005 110.848 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -96.39 -77.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 7.1 m -106.37 132.4 20.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 53.039999999999999 110.93 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.79 -7.98 22.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.691 2.261 . . . . 75.099999999999994 112.3 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.4 pp -75.01 -2.19 26.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 50.299999999999997 110.956 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.58 14.02 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.439999999999998 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -22.97 12.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 45.149999999999999 112.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -83.71 -59.62 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 73.109999999999999 110.913 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -93.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 44.109999999999999 112.5 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 75.420000000000002 112.461 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.807 0.337 . . . . 71.340000000000003 111.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.02 43.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 111.093 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.52 -24.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.97 -18.18 2.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 54.039999999999999 112.495 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 38.9 p-90 -55.24 -34.59 64.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 74.329999999999998 110.88 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -13.92 59.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 72.409999999999997 110.954 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -75.42 -76.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.230000000000004 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -93.29 -81.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 24.1 m -112.51 131.03 22.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.577 0.703 . . . . 71.019999999999996 110.884 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.75 -10.83 29.52 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.65 2.234 . . . . 62.210000000000001 112.335 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -9.29 52.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.200000000000003 110.903 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -79.34 57.13 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 64.150000000000006 110.885 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.17 -22.69 67.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 63.409999999999997 112.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.06 -26.97 5.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.14 -99.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.67 -0.776 . . . . 73.439999999999998 112.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 52.200000000000003 112.508 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.867 0.365 . . . . 63.32 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.98 55.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 70.349999999999994 111.094 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -21.31 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.400000000000006 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.38 -20.9 24.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 72.209999999999994 112.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.518 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 1.2 p-90 -62.89 -25.4 68.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 64.239999999999995 110.927 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -11.3 31.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 50.009999999999998 110.891 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -82.29 -81.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.099999999999994 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -98.57 -80.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.120000000000005 110.875 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -68.19 119.41 67.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.655 0.741 . . . . 70.319999999999993 110.904 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.628 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.2 Cg_endo -69.7 -11.92 31.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 73.219999999999999 112.389 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.67 24.79 9.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.943 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.55 55.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.42 25.59 19.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.799 -0.715 . . . . 51.009999999999998 112.496 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -119.84 -32.1 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 73.010000000000005 110.853 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.16 -88.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 74.019999999999996 112.521 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 51.439999999999998 112.504 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.887 0.375 . . . . 75.439999999999998 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.61 64.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 62.32 111.114 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -12.3 58.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.843 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.98 -13.22 18.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.779 -0.724 . . . . 52.420000000000002 112.483 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -69.86 -37.25 76.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 72.239999999999995 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -18.42 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 72.030000000000001 110.863 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -65.04 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 73.219999999999999 110.872 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -96.27 -77.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 110.897 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 59.3 m -107.31 131.97 21.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 43.149999999999999 110.878 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 -8.82 24.56 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.677 2.251 . . . . 70.120000000000005 112.317 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.33 -5.84 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.18 46.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.851 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.9 87.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.299999999999997 112.501 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -19.87 9.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 64.329999999999998 110.909 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.64 -97.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 70.400000000000006 112.486 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 54.109999999999999 112.515 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.857 0.36 . . . . 53.409999999999997 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.25 73.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.083 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.97 -12.89 29.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 54.340000000000003 110.868 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.12 15.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 63.450000000000003 112.515 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.489 ' CE2' ' HG3' ' A' ' 6' ' ' LYS . 5.3 p-90 -57.43 -30.41 64.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 72.150000000000006 110.909 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 1.2 mtpm? -76.11 -13.7 60.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 110.874 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -71.49 -80.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -99.04 -79.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 74.549999999999997 110.916 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 25.8 p -101.59 131.58 22.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.608 0.718 . . . . 71.530000000000001 110.895 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.76 -8.17 22.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 51.119999999999997 112.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.1 pp -79.89 0.33 31.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 72.019999999999996 110.892 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -88.91 40.04 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.540000000000006 110.899 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 -13.42 83.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -98.55 -30.52 12.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 74.019999999999996 110.929 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.62 -95.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 72.400000000000006 112.512 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.764 -0.732 . . . . 50.43 112.481 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 61.140000000000001 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 12' ' ' PHE . . . -119.62 71.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 70.049999999999997 111.093 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -23.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 64.319999999999993 110.888 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.49 -14.88 22.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 73.239999999999995 112.483 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 12' ' ' PHE . 5.6 p-90 -58.26 -40.01 80.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.845 0.355 . . . . 73.109999999999999 110.893 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -15.56 60.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 63.530000000000001 110.919 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.904 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -78.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.150000000000006 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 1.2 m -112.36 128.84 24.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.59 0.71 . . . . 73.420000000000002 110.906 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.4 26.02 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 72.209999999999994 112.315 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.27 -11.75 44.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.019999999999996 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 9.4 m-85 -77.66 57.15 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 62.109999999999999 110.902 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.27 -24.22 67.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 44.409999999999997 112.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -28.25 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 74.209999999999994 110.907 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.83 -99.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 74.010000000000005 112.465 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 70.510000000000005 112.501 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.865 0.364 . . . . 71.030000000000001 111.133 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.06 72.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.019999999999996 111.108 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -12.95 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 71.230000000000004 110.885 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -61.13 -12.4 30.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 41.200000000000003 112.495 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.7 p-90 -67.51 -38.43 84.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.808 0.337 . . . . 65.530000000000001 110.886 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -22.21 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 64.010000000000005 110.923 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.2 mmt180 -60.84 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.838 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -96.0 -77.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.420000000000002 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 67.5 m -106.96 131.48 21.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.624 0.726 . . . . 62.109999999999999 110.91 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 -8.58 23.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 73.519999999999996 112.356 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.7 pp -71.57 -4.96 29.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 110.886 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 63.340000000000003 110.884 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -12.18 69.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 71.329999999999998 112.47 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -115.71 -27.99 6.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 72.120000000000005 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.3 -89.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.019999999999996 112.499 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.499 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLY . . . -95.76 57.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.539999999999999 111.14 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -56.57 -21.71 28.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.878 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.01 -21.63 17.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 75.349999999999994 112.461 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER -66.93 -20.71 65.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 74.030000000000001 110.919 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 -13.69 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 72.439999999999998 110.892 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -79.08 -85.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 75.219999999999999 110.839 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -98.11 -77.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.91 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 19.2 m -65.25 114.02 13.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.617 0.722 . . . . 71.230000000000004 110.914 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.661 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.4 Cg_endo -69.79 -10.76 29.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.129999999999995 112.317 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.87 24.82 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.200000000000003 110.89 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.85 47.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 72.450000000000003 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.93 -43.47 73.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 70.400000000000006 112.527 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -31.83 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 61.420000000000002 110.91 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.72 -88.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 43.32 112.484 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 74.340000000000003 112.432 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.852 0.358 . . . . 74.049999999999997 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.08 72.54 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 111.112 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.03 -11.92 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 73.439999999999998 110.852 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -60.5 -12.62 26.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 71.400000000000006 112.479 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -68.84 -37.89 79.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 73.120000000000005 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 -19.83 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 54.119999999999997 110.851 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.3 mmt180 -63.45 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.420000000000002 110.858 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 -77.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 63.520000000000003 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 31.1 m -105.13 130.93 22.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 71.549999999999997 110.832 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.81 -8.52 23.81 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.274 . . . . 74.430000000000007 112.35 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.83 -5.18 36.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 75.25 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.76 44.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 110.885 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.11 -14.0 83.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 54.130000000000003 112.491 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -29.74 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 73.549999999999997 110.862 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -89.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 74.040000000000006 112.536 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 64.439999999999998 112.483 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.819 0.342 . . . . 73.439999999999998 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.29 66.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 75.040000000000006 111.092 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.57 -11.62 60.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.150000000000006 110.838 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.98 -13.92 15.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 61.200000000000003 112.477 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.0 p-90 -71.65 -35.74 70.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 62.119999999999997 110.931 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -17.32 60.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 74.209999999999994 110.84 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -83.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 55.509999999999998 110.866 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -77.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 58.8 m -105.26 132.81 20.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.625 0.726 . . . . 75.319999999999993 110.907 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.75 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 64.030000000000001 112.381 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.3 pp -76.11 -3.06 34.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.972 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.03 3.72 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 110.895 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.91 -29.0 13.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 61.009999999999998 112.485 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 -32.0 21.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 73.109999999999999 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.49 -97.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 63.439999999999998 112.499 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.707 -0.759 . . . . 72.120000000000005 112.465 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.778 0.323 . . . . 64.420000000000002 111.128 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . -102.05 68.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 32.509999999999998 111.1 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -61.37 -56.33 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.439999999999998 110.891 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -25.02 6.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 44.539999999999999 112.547 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.509 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.7 m95 -96.52 -28.83 14.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 75.25 110.945 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -49.21 -38.41 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.150000000000006 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -58.08 -55.73 31.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.129999999999995 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.23 -75.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 115.03 32.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 71.439999999999998 110.884 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -17.07 37.84 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.711 2.274 . . . . 75.219999999999999 112.383 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -84.15 5.04 27.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.897 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.18 66.92 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 110.886 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -77.1 56.78 3.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 72.239999999999995 112.432 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -96.28 -75.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 73.430000000000007 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -111.78 3.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 74.209999999999994 112.49 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 51.539999999999999 112.471 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.805 0.336 . . . . 45.219999999999999 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.15 61.98 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 34.329999999999998 111.139 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -15.42 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 74.230000000000004 110.866 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.7 -13.97 27.08 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 70.5 112.435 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 4.6 p-90 -63.66 -37.9 89.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 110.914 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -75.61 -14.31 60.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -73.08 -77.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 64.519999999999996 110.899 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -80.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 63.200000000000003 110.929 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -107.79 128.35 26.01 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.572 0.701 . . . . 75.120000000000005 110.842 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 -9.39 26.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.668 2.245 . . . . 70.129999999999995 112.324 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.6 pp -67.32 -10.66 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.941 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 10.3 m-85 -78.32 56.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.891 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.43 -26.12 72.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 41.329999999999998 112.524 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -28.48 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 71.049999999999997 110.886 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.27 -96.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 41.350000000000001 112.455 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 73.310000000000002 112.516 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.338 . . . . 63.409999999999997 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.16 72.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.400000000000006 111.139 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -12.42 35.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 75.310000000000002 110.861 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.79 -12.39 27.95 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 63.310000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.4 p-90 -69.04 -38.94 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 54.229999999999997 110.907 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -71.27 -22.3 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 110.893 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -60.7 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 110.868 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -96.63 -77.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.349999999999994 110.908 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 69.6 m -105.58 131.61 21.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.621 0.724 . . . . 55.340000000000003 110.887 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.76 -8.41 23.53 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.672 2.248 . . . . 73.409999999999997 112.359 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -76.19 -4.28 40.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 61.310000000000002 110.929 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.6 55.55 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.865 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.56 -30.74 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 72.129999999999995 112.453 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -63.54 -75.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 52.119999999999997 110.937 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 60.340000000000003 112.519 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 54.409999999999997 112.48 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.806 0.336 . . . . 43.439999999999998 111.147 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . -94.98 63.4 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 64.340000000000003 111.118 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -53.77 54.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 62.020000000000003 110.868 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.09 -23.42 11.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 35.130000000000003 112.495 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.684 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.6 m95 -95.74 -32.03 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 72.5 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -46.12 -46.5 17.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.200000000000003 110.886 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -45.35 -56.8 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 73.329999999999998 110.872 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -90.47 -76.04 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 64.400000000000006 110.908 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -120.49 102.44 45.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.631 0.729 . . . . 73.450000000000003 110.917 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 9' ' ' CYS . 53.6 Cg_endo -69.81 -13.86 35.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 61.020000000000003 112.342 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -5.81 38.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.89 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -93.47 69.52 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 65.349999999999994 110.863 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -74.36 58.85 2.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 73.109999999999999 112.519 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -101.86 -73.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 74.519999999999996 110.92 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 -112.19 3.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 65.340000000000003 112.47 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' N ' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 63.210000000000001 112.481 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 73.140000000000001 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.77 75.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.109999999999999 111.1 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -10.13 22.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.864 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.51 -11.82 4.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.799 -0.715 . . . . 40.509999999999998 112.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.6 m95 -37.12 -77.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.801 0.334 . . . . 73.030000000000001 110.887 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -66.16 -30.56 71.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.230000000000004 110.91 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 13.2 mtp180 -55.53 -78.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.319999999999993 110.9 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -96.61 -78.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.400000000000006 110.859 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -121.81 130.14 24.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 73.25 110.947 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -4.96 15.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 65.329999999999998 112.341 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.78 10.09 24.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.894 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.62 39.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 61.130000000000003 110.897 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.42 -21.63 57.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 61.32 112.463 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -31.98 72.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 44.25 110.852 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.68 -92.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 54.25 112.491 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 73.310000000000002 112.482 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.854 0.359 . . . . 74.519999999999996 111.106 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HB1' ' HE1' ' A' ' 5' ' ' TRP . . . -120.61 74.79 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 111.103 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -99.96 -16.84 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.409999999999997 110.856 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.37 -13.28 3.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 71.420000000000002 112.505 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 2' ' ' ALA . 21.8 m95 -41.85 -76.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 75.329999999999998 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -76.39 -14.92 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 71.209999999999994 110.896 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -79.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.549999999999997 110.865 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -93.06 -75.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.915 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.47 128.74 25.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.709 . . . . 62.299999999999997 110.87 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.5 Cg_endo -69.72 -5.31 15.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 74.150000000000006 112.376 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.55 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -110.96 10.49 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 61.049999999999997 110.937 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -94.44 63.46 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.120000000000005 110.866 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.61 20.43 41.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 75.310000000000002 112.456 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 -19.69 8.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 64.310000000000002 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.18 -76.44 0.58 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 53.240000000000002 112.46 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 64.530000000000001 112.472 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.847 0.356 . . . . 75.310000000000002 111.097 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.88 75.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 64.5 111.087 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -9.84 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.540000000000006 110.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.38 -12.07 4.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 50.409999999999997 112.536 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m95 -36.56 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 61.130000000000003 110.943 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -30.76 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 74.400000000000006 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.529 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.4 mtp180 -55.26 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.530000000000001 110.877 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -96.59 -78.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 64.439999999999998 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.9 130.12 24.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.623 0.725 . . . . 74.430000000000007 110.898 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 53.4 Cg_endo -69.82 -4.5 14.19 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.667 2.245 . . . . 73.150000000000006 112.282 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 11' ' ' LEU . 1.9 pp -104.69 3.52 31.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 74.120000000000005 110.961 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -88.84 60.87 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 74.400000000000006 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.97 6.05 76.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 64.299999999999997 112.508 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -29.82 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 70.299999999999997 110.881 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.89 -89.11 1.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.129999999999995 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 75.129999999999995 112.466 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.32 59.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 111.099 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -12.57 58.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.239999999999995 110.866 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.95 -12.98 17.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 72.510000000000005 112.452 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -70.23 -37.49 75.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 71.400000000000006 110.931 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -18.19 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 64.340000000000003 110.884 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -65.28 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 110.884 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -77.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 110.878 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 18.8 p -104.45 130.73 22.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 71.450000000000003 110.831 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 -9.91 27.26 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.699 2.266 . . . . 74.329999999999998 112.318 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.13 -4.02 36.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 71.409999999999997 110.939 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 56.34 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.17 27.0 11.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 72.129999999999995 112.527 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.12 -68.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 71.530000000000001 110.859 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.92 -103.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 73.040000000000006 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 70.450000000000003 112.451 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.807 0.337 . . . . 61.210000000000001 111.099 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.75 51.29 2.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 43.25 111.068 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -13.62 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 74.129999999999995 110.878 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.6 -19.03 17.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 44.420000000000002 112.513 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -80.11 -17.66 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 62.530000000000001 110.969 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 47.0 mmtt -78.41 -14.76 59.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.209999999999994 110.904 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -85.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 74.150000000000006 110.851 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -80.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.932 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -53.55 109.12 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 71.5 110.931 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.5 Cg_endo -69.78 -12.74 33.47 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.663 2.242 . . . . 61.420000000000002 112.336 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.12 25.54 9.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.239999999999995 110.922 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 4.56 14.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 72.209999999999994 110.886 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.91 -30.13 6.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 42.100000000000001 112.486 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -40.8 95.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 62.229999999999997 110.895 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.83 -96.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 63.520000000000003 112.474 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 72.219999999999999 112.499 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.808 0.337 . . . . 51.210000000000001 111.13 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' HA2' ' A' ' 16' ' ' GLY . . . -95.86 54.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 70.549999999999997 111.131 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -13.87 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 110.826 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.42 18.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 60.219999999999999 112.49 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -76.8 -14.09 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 61.200000000000003 110.935 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -86.54 -14.04 44.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.892 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -78.92 -82.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.319999999999993 110.876 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.25 -80.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 73.310000000000002 110.883 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 20.2 m -62.45 112.19 6.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 64.450000000000003 110.894 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.556 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.4 Cg_endo -69.72 -10.54 28.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 62.350000000000001 112.368 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -120.51 25.03 10.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.914 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -80.08 8.25 7.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 71.439999999999998 110.848 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.06 -29.4 8.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 72.439999999999998 112.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.5 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 61.109999999999999 110.916 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 -92.38 1.82 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 54.310000000000002 112.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 64.010000000000005 112.525 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 41.14 111.109 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -90.93 -11.61 38.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.11 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.78 -13.03 23.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 75.34 112.479 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.3 p-90 -70.04 -37.24 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.341 . . . . 74.24 110.9 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 -18.68 61.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 72.43 110.935 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.12 110.848 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -96.39 -77.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.44 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 7.1 m -106.37 132.4 20.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 53.04 110.93 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.79 -7.98 22.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.691 2.261 . . . . 75.1 112.3 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.605 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.4 pp -75.01 -2.19 26.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 50.3 110.956 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.58 14.02 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.44 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -22.97 12.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 45.15 112.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -83.71 -59.62 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 73.11 110.913 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -93.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 44.11 112.5 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 75.42 112.461 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.736 0.303 . . . . 75.45 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.52 -24.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.97 -18.18 2.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 54.04 112.495 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 38.9 p-90 -55.24 -34.59 64.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 74.33 110.88 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -13.92 59.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.954 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -75.42 -76.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.23 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -93.29 -81.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 24.1 m -112.51 131.03 22.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.577 0.703 . . . . 71.02 110.884 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.75 -10.83 29.52 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.65 2.234 . . . . 62.21 112.335 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -9.29 52.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.903 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -79.34 57.13 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 64.15 110.885 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.17 -22.69 67.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 63.41 112.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.06 -26.97 5.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.43 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.14 -99.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 52.2 112.508 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.759 0.314 . . . . 70.35 111.094 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -21.31 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.4 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.38 -20.9 24.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 72.21 112.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.518 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 1.2 p-90 -62.89 -25.4 68.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 64.24 110.927 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -11.3 31.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 50.01 110.891 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -82.29 -81.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -98.57 -80.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.875 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -68.19 119.41 67.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.655 0.741 . . . . 70.32 110.904 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.628 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.2 Cg_endo -69.7 -11.92 31.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 73.22 112.389 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.67 24.79 9.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.4 110.943 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.55 55.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.42 25.59 19.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.799 -0.715 . . . . 51.01 112.496 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -119.84 -32.1 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 73.01 110.853 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.16 -88.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 74.02 112.521 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 51.44 112.504 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.813 0.34 . . . . 62.32 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -12.3 58.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.843 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.98 -13.22 18.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.779 -0.724 . . . . 52.42 112.483 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -69.86 -37.25 76.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 72.24 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -18.42 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 72.03 110.863 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -65.04 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 73.22 110.872 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -96.27 -77.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.897 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 59.3 m -107.31 131.97 21.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 43.15 110.878 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 -8.82 24.56 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.677 2.251 . . . . 70.12 112.317 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.33 -5.84 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.18 46.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.851 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.9 87.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.3 112.501 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -19.87 9.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 64.33 110.909 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.64 -97.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 70.4 112.486 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 54.11 112.515 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.813 0.339 . . . . 74.44 111.083 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.97 -12.89 29.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 54.34 110.868 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.12 15.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 63.45 112.515 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.489 ' CE2' ' HG3' ' A' ' 6' ' ' LYS . 5.3 p-90 -57.43 -30.41 64.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 72.15 110.909 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 1.2 mtpm? -76.11 -13.7 60.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.874 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -71.49 -80.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 75.33 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -99.04 -79.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 74.55 110.916 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 25.8 p -101.59 131.58 22.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.608 0.718 . . . . 71.53 110.895 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.76 -8.17 22.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 51.12 112.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.1 pp -79.89 0.33 31.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 72.02 110.892 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -88.91 40.04 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.54 110.899 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 -13.42 83.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 72.44 112.485 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -98.55 -30.52 12.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 74.02 110.929 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.62 -95.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 72.4 112.512 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.764 -0.732 . . . . 50.43 112.481 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 12' ' ' PHE . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.797 0.332 . . . . 70.05 111.093 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -23.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 64.32 110.888 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.49 -14.88 22.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 73.24 112.483 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 5.6 p-90 -58.26 -40.01 80.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.845 0.355 . . . . 73.11 110.893 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -15.56 60.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 63.53 110.919 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.904 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -78.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 1.2 m -112.36 128.84 24.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.59 0.71 . . . . 73.42 110.906 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.4 26.02 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 72.21 112.315 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.27 -11.75 44.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.02 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 9.4 m-85 -77.66 57.15 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 62.11 110.902 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.27 -24.22 67.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 44.41 112.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -28.25 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 74.21 110.907 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.83 -99.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 74.01 112.465 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 70.51 112.501 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.766 0.317 . . . . 71.02 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -12.95 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 71.23 110.885 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -61.13 -12.4 30.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 41.2 112.495 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.7 p-90 -67.51 -38.43 84.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.808 0.337 . . . . 65.53 110.886 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -22.21 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 64.01 110.923 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.2 mmt180 -60.84 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.838 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -96.0 -77.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.42 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 67.5 m -106.96 131.48 21.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.624 0.726 . . . . 62.11 110.91 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 -8.58 23.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 73.52 112.356 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.7 pp -71.57 -4.96 29.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.43 110.886 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 63.34 110.884 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -12.18 69.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 71.33 112.47 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -115.71 -27.99 6.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 72.12 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.3 -89.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.02 112.499 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.499 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.815 0.34 . . . . 62.54 111.14 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -56.57 -21.71 28.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.878 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.01 -21.63 17.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 75.35 112.461 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER -66.93 -20.71 65.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 74.03 110.919 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 -13.69 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.892 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -79.08 -85.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 75.22 110.839 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -98.11 -77.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.91 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 19.2 m -65.25 114.02 13.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.617 0.722 . . . . 71.23 110.914 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.661 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.4 Cg_endo -69.79 -10.76 29.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.13 112.317 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.87 24.82 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.89 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.85 47.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 72.45 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.93 -43.47 73.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 70.4 112.527 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -31.83 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 61.42 110.91 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.72 -88.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 43.32 112.484 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 74.34 112.432 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.766 0.317 . . . . 64.23 111.112 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.03 -11.92 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 73.44 110.852 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -60.5 -12.62 26.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 71.4 112.479 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -68.84 -37.89 79.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 73.12 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 -19.83 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 54.12 110.851 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.3 mmt180 -63.45 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.858 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 -77.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 63.52 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 31.1 m -105.13 130.93 22.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 71.55 110.832 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.81 -8.52 23.81 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.274 . . . . 74.43 112.35 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.83 -5.18 36.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 75.25 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.76 44.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.885 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.11 -14.0 83.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 54.13 112.491 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -29.74 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 73.55 110.862 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -89.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 74.04 112.536 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 64.44 112.483 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.798 0.332 . . . . 75.04 111.092 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.57 -11.62 60.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.15 110.838 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.98 -13.92 15.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 61.2 112.477 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.0 p-90 -71.65 -35.74 70.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 62.12 110.931 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -17.32 60.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.84 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -83.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 55.51 110.866 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -77.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.32 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 58.8 m -105.26 132.81 20.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.625 0.726 . . . . 75.32 110.907 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.75 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 64.03 112.381 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.3 pp -76.11 -3.06 34.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.972 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.03 3.72 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.15 110.895 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.91 -29.0 13.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 61.01 112.485 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 -32.0 21.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 73.11 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.49 -97.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 63.44 112.499 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.707 -0.759 . . . . 72.12 112.465 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.782 0.325 . . . . 32.51 111.1 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -61.37 -56.33 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.44 110.891 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -25.02 6.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 44.54 112.547 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.509 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.7 m95 -96.52 -28.83 14.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 75.25 110.945 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -49.21 -38.41 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.15 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -58.08 -55.73 31.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.13 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.23 -75.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 115.03 32.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 71.44 110.884 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -17.07 37.84 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.711 2.274 . . . . 75.22 112.383 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -84.15 5.04 27.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.897 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.18 66.92 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.43 110.886 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -77.1 56.78 3.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 72.24 112.432 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -96.28 -75.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 73.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -111.78 3.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 74.21 112.49 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 51.54 112.471 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.796 0.331 . . . . 34.33 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -15.42 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.866 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.7 -13.97 27.08 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 70.5 112.435 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 4.6 p-90 -63.66 -37.9 89.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.41 110.914 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -75.61 -14.31 60.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -73.08 -77.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 64.52 110.899 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -80.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.929 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -107.79 128.35 26.01 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.572 0.701 . . . . 75.12 110.842 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 -9.39 26.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.668 2.245 . . . . 70.13 112.324 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.6 pp -67.32 -10.66 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.941 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 10.3 m-85 -78.32 56.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.31 110.891 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.43 -26.12 72.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 41.33 112.524 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -28.48 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 71.05 110.886 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.27 -96.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 41.35 112.455 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 73.31 112.516 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.793 0.33 . . . . 74.4 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -12.42 35.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.861 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.79 -12.39 27.95 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 63.31 112.478 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.4 p-90 -69.04 -38.94 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 54.23 110.907 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -71.27 -22.3 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.893 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -60.7 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.868 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -96.63 -77.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.35 110.908 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 69.6 m -105.58 131.61 21.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.621 0.724 . . . . 55.34 110.887 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.76 -8.41 23.53 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.672 2.248 . . . . 73.41 112.359 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -76.19 -4.28 40.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 61.31 110.929 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.6 55.55 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.865 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.56 -30.74 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 72.13 112.453 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -63.54 -75.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 52.12 110.937 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 60.34 112.519 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 54.41 112.48 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.764 0.316 . . . . 64.34 111.118 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -53.77 54.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 62.02 110.868 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.09 -23.42 11.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 35.13 112.495 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.684 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.6 m95 -95.74 -32.03 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 72.5 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -46.12 -46.5 17.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.2 110.886 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -45.35 -56.8 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 73.33 110.872 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -90.47 -76.04 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 64.4 110.908 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -120.49 102.44 45.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.631 0.729 . . . . 73.45 110.917 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 9' ' ' CYS . 53.6 Cg_endo -69.81 -13.86 35.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 61.02 112.342 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -5.81 38.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.89 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -93.47 69.52 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 65.35 110.863 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -74.36 58.85 2.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 73.11 112.519 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -101.86 -73.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 74.52 110.92 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 -112.19 3.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 65.34 112.47 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' N ' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 63.21 112.481 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.806 0.336 . . . . 72.11 111.1 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -10.13 22.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.864 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.51 -11.82 4.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.799 -0.715 . . . . 40.51 112.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.6 m95 -37.12 -77.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.801 0.334 . . . . 73.03 110.887 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -66.16 -30.56 71.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.91 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 13.2 mtp180 -55.53 -78.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.9 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -96.61 -78.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.4 110.859 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -121.81 130.14 24.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 73.25 110.947 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -4.96 15.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 65.33 112.341 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.78 10.09 24.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.894 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.62 39.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 61.13 110.897 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.42 -21.63 57.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 61.32 112.463 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -31.98 72.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 44.25 110.852 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.68 -92.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 54.25 112.491 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 73.31 112.482 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HB1' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.781 0.324 . . . . 71.22 111.103 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -99.96 -16.84 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.856 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.37 -13.28 3.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 71.42 112.505 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 2' ' ' ALA . 21.8 m95 -41.85 -76.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 75.33 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -76.39 -14.92 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 71.21 110.896 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -79.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.55 110.865 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -93.06 -75.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.915 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.47 128.74 25.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.709 . . . . 62.3 110.87 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.5 Cg_endo -69.72 -5.31 15.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 74.15 112.376 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.55 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -110.96 10.49 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 61.05 110.937 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -94.44 63.46 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.12 110.866 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.61 20.43 41.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 75.31 112.456 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 -19.69 8.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 64.31 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.18 -76.44 0.58 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 53.24 112.46 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 64.53 112.472 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.799 0.333 . . . . 64.5 111.087 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -9.84 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.38 -12.07 4.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 50.41 112.536 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m95 -36.56 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 61.13 110.943 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -30.76 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.529 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.4 mtp180 -55.26 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.877 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -96.59 -78.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 64.44 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.9 130.12 24.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.623 0.725 . . . . 74.43 110.898 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 53.4 Cg_endo -69.82 -4.5 14.19 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.667 2.245 . . . . 73.15 112.282 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.9 pp -104.69 3.52 31.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 74.12 110.961 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -88.84 60.87 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.97 6.05 76.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 64.3 112.508 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -29.82 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 70.3 110.881 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.89 -89.11 1.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.13 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 75.13 112.466 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.756 0.313 . . . . 73.32 111.099 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -12.57 58.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.866 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.95 -12.98 17.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 72.51 112.452 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -70.23 -37.49 75.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 71.4 110.931 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -18.19 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 64.34 110.884 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -65.28 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 64.44 110.884 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -77.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.878 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 18.8 p -104.45 130.73 22.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 71.45 110.831 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 -9.91 27.26 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.699 2.266 . . . . 74.33 112.318 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.13 -4.02 36.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 71.41 110.939 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 56.34 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.17 27.0 11.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 72.13 112.527 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.12 -68.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 71.53 110.859 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.92 -103.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 73.04 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 70.45 112.451 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.768 0.318 . . . . 43.25 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -13.62 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 74.13 110.878 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.6 -19.03 17.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 44.42 112.513 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -80.11 -17.66 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 62.53 110.969 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 47.0 mmtt -78.41 -14.76 59.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.904 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -85.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 74.15 110.851 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -80.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.45 110.932 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -53.55 109.12 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 71.5 110.931 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.5 Cg_endo -69.78 -12.74 33.47 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.663 2.242 . . . . 61.42 112.336 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.12 25.54 9.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.922 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 4.56 14.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 72.21 110.886 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.91 -30.13 6.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 42.1 112.486 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -40.8 95.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 62.23 110.895 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.83 -96.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 63.52 112.474 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 72.22 112.499 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' HA2' ' A' ' 16' ' ' GLY . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.847 0.356 . . . . 70.55 111.131 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -13.87 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.826 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.42 18.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 60.22 112.49 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -76.8 -14.09 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 61.2 110.935 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -86.54 -14.04 44.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.892 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -78.92 -82.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.32 110.876 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.25 -80.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.883 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 20.2 m -62.45 112.19 6.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 64.45 110.894 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.556 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.4 Cg_endo -69.72 -10.54 28.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 62.35 112.368 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -120.51 25.03 10.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.914 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -80.08 8.25 7.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 71.44 110.848 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.06 -29.4 8.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.5 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 61.11 110.916 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 -92.38 1.82 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 54.31 112.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 64.01 112.525 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.854 0.359 . . . . 71.12 111.113 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.45 74.01 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 41.14 111.109 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -90.93 -11.61 38.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.11 110.851 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.78 -13.03 23.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.733 -0.746 . . . . 75.34 112.479 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.3 p-90 -70.04 -37.24 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.341 . . . . 74.24 110.9 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 -18.68 61.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 72.43 110.935 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.12 110.848 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -96.39 -77.2 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.44 110.903 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 7.1 m -106.37 132.4 20.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 53.04 110.93 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.79 -7.98 22.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.691 2.261 . . . . 75.1 112.3 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.605 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.4 pp -75.01 -2.19 26.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 50.3 110.956 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.58 14.02 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 71.44 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -22.97 12.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 45.15 112.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -83.71 -59.62 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 73.11 110.913 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.24 -93.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 44.11 112.5 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 75.42 112.461 -179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.807 0.337 . . . . 71.34 111.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.02 43.33 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.45 111.093 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.52 -24.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.889 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.97 -18.18 2.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.731 . . . . 54.04 112.495 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 38.9 p-90 -55.24 -34.59 64.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 74.33 110.88 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -13.92 59.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.954 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -75.42 -76.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.23 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -93.29 -81.05 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 24.1 m -112.51 131.03 22.83 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.577 0.703 . . . . 71.02 110.884 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.75 -10.83 29.52 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.65 2.234 . . . . 62.21 112.335 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -9.29 52.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.903 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -79.34 57.13 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 64.15 110.885 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.17 -22.69 67.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 63.41 112.494 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.06 -26.97 5.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 74.43 110.904 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.14 -99.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 52.2 112.508 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.867 0.365 . . . . 63.32 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.98 55.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 70.35 111.094 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -21.31 55.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.4 110.892 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.38 -20.9 24.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 72.21 112.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.518 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 1.2 p-90 -62.89 -25.4 68.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.862 0.363 . . . . 64.24 110.927 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -11.3 31.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 50.01 110.891 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -82.29 -81.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -98.57 -80.33 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.875 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -68.19 119.41 67.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.655 0.741 . . . . 70.32 110.904 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.628 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.2 Cg_endo -69.7 -11.92 31.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.686 2.257 . . . . 73.22 112.389 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.67 24.79 9.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.4 110.943 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.55 55.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.42 25.59 19.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.799 -0.715 . . . . 51.01 112.496 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -119.84 -32.1 4.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 73.01 110.853 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.16 -88.57 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 74.02 112.521 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.777 -0.725 . . . . 51.44 112.504 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.887 0.375 . . . . 75.44 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.61 64.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 62.32 111.114 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -12.3 58.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.843 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.98 -13.22 18.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.779 -0.724 . . . . 52.42 112.483 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -69.86 -37.25 76.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 72.24 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -18.42 60.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 72.03 110.863 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -65.04 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 73.22 110.872 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -96.27 -77.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.897 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 59.3 m -107.31 131.97 21.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.643 0.735 . . . . 43.15 110.878 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 -8.82 24.56 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.677 2.251 . . . . 70.12 112.317 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.33 -5.84 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.18 46.18 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.851 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.9 87.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 74.3 112.501 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -19.87 9.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 64.33 110.909 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.64 -97.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.696 -0.764 . . . . 70.4 112.486 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.735 -0.745 . . . . 54.11 112.515 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.857 0.36 . . . . 53.41 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.25 73.31 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.083 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.97 -12.89 29.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 54.34 110.868 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.12 15.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 63.45 112.515 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.489 ' CE2' ' HG3' ' A' ' 6' ' ' LYS . 5.3 p-90 -57.43 -30.41 64.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 72.15 110.909 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 1.2 mtpm? -76.11 -13.7 60.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.874 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 mtp-105 -71.49 -80.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 75.33 110.881 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -99.04 -79.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 74.55 110.916 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 25.8 p -101.59 131.58 22.78 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.608 0.718 . . . . 71.53 110.895 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.76 -8.17 22.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.677 2.251 . . . . 51.12 112.343 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.1 pp -79.89 0.33 31.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 72.02 110.892 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -88.91 40.04 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.54 110.899 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 -13.42 83.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 72.44 112.485 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -98.55 -30.52 12.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 74.02 110.929 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.62 -95.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.772 -0.727 . . . . 72.4 112.512 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.764 -0.732 . . . . 50.43 112.481 -179.926 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 61.14 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 12' ' ' PHE . . . -119.62 71.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 70.05 111.093 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -23.5 19.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 64.32 110.888 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.49 -14.88 22.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 73.24 112.483 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 5.6 p-90 -58.26 -40.01 80.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.845 0.355 . . . . 73.11 110.893 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -15.56 60.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.443 . . . . 63.53 110.919 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.14 -79.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.904 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 -78.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.86 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 1.2 m -112.36 128.84 24.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.59 0.71 . . . . 73.42 110.906 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.4 26.02 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 72.21 112.315 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.27 -11.75 44.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 72.02 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 9.4 m-85 -77.66 57.15 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 62.11 110.902 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.27 -24.22 67.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 44.41 112.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -28.25 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.834 0.35 . . . . 74.21 110.907 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.83 -99.41 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 74.01 112.465 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 70.51 112.501 -179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.865 0.364 . . . . 71.03 111.133 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.06 72.6 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.02 111.108 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.84 -12.95 32.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.267 -0.424 . . . . 71.23 110.885 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -61.13 -12.4 30.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.714 -0.755 . . . . 41.2 112.495 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.7 p-90 -67.51 -38.43 84.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.808 0.337 . . . . 65.53 110.886 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -22.21 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 64.01 110.923 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.2 mmt180 -60.84 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.838 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -96.0 -77.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.42 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 67.5 m -106.96 131.48 21.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.624 0.726 . . . . 62.11 110.91 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 -8.58 23.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.266 . . . . 73.52 112.356 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.7 pp -71.57 -4.96 29.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 75.43 110.886 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.32 38.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 63.34 110.884 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -12.18 69.17 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 71.33 112.47 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -115.71 -27.99 6.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 72.12 110.94 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.3 -89.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.02 112.499 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.499 -179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.826 0.346 . . . . 75.14 111.146 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 16' ' ' GLY . . . -95.76 57.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 62.54 111.14 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -56.57 -21.71 28.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.878 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.01 -21.63 17.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 75.35 112.461 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.52 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 0.9 OUTLIER -66.93 -20.71 65.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.848 0.356 . . . . 74.03 110.919 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 -13.69 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 72.44 110.892 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -79.08 -85.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 75.22 110.839 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -98.11 -77.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.91 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 19.2 m -65.25 114.02 13.69 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.617 0.722 . . . . 71.23 110.914 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.661 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.4 Cg_endo -69.79 -10.76 29.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.679 2.253 . . . . 73.13 112.317 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.87 24.82 10.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.89 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.85 47.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 72.45 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.93 -43.47 73.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.753 . . . . 70.4 112.527 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 -31.83 30.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 61.42 110.91 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.72 -88.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 43.32 112.484 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 74.34 112.432 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.852 0.358 . . . . 74.05 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.08 72.54 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 64.23 111.112 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -91.03 -11.92 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 73.44 110.852 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 7' ' ' ARG . . . -60.5 -12.62 26.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 71.4 112.479 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.6 p-90 -68.84 -37.89 79.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 73.12 110.914 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.88 -19.83 61.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 54.12 110.851 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 3.3 mmt180 -63.45 -82.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.858 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 -77.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 63.52 110.895 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 31.1 m -105.13 130.93 22.28 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.645 0.736 . . . . 71.55 110.832 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.81 -8.52 23.81 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.274 . . . . 74.43 112.35 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.83 -5.18 36.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 75.25 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.76 44.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.885 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.11 -14.0 83.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 54.13 112.491 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 -29.74 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 73.55 110.862 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -89.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.751 -0.738 . . . . 74.04 112.536 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 64.44 112.483 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.819 0.342 . . . . 73.44 111.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.29 66.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 75.04 111.092 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.57 -11.62 60.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 72.15 110.838 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.98 -13.92 15.51 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.731 -0.747 . . . . 61.2 112.477 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.0 p-90 -71.65 -35.74 70.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.339 . . . . 62.12 110.931 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -17.32 60.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.84 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.67 -83.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 55.51 110.866 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -77.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.32 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 58.8 m -105.26 132.81 20.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.625 0.726 . . . . 75.32 110.907 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.75 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 64.03 112.381 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.3 pp -76.11 -3.06 34.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.972 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.03 3.72 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 73.15 110.895 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.91 -29.0 13.11 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 61.01 112.485 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.14 -32.0 21.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.825 0.345 . . . . 73.11 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.49 -97.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 63.44 112.499 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.707 -0.759 . . . . 72.12 112.465 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 56.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.778 0.323 . . . . 64.42 111.128 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . -102.05 68.83 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 32.51 111.1 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -61.37 -56.33 21.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.44 110.891 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -25.02 6.79 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.709 -0.758 . . . . 44.54 112.547 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.509 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.7 m95 -96.52 -28.83 14.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 75.25 110.945 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -49.21 -38.41 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 64.15 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -58.08 -55.73 31.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.13 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.23 -75.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.881 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.7 115.03 32.42 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 71.44 110.884 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -17.07 37.84 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.711 2.274 . . . . 75.22 112.383 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -84.15 5.04 27.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.897 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.18 66.92 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.43 110.886 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -77.1 56.78 3.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.747 . . . . 72.24 112.432 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -96.28 -75.88 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 73.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.81 -111.78 3.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 74.21 112.49 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 51.54 112.471 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.805 0.336 . . . . 45.22 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.15 61.98 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 34.33 111.139 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -15.42 57.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.866 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.7 -13.97 27.08 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 70.5 112.435 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 4.6 p-90 -63.66 -37.9 89.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 72.41 110.914 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -75.61 -14.31 60.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.947 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 37.9 mtp85 -73.08 -77.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 64.52 110.899 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.2 -80.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.929 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -107.79 128.35 26.01 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.572 0.701 . . . . 75.12 110.842 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 -9.39 26.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.668 2.245 . . . . 70.13 112.324 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.6 pp -67.32 -10.66 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.941 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 5' ' ' TRP . 10.3 m-85 -78.32 56.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.31 110.891 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.43 -26.12 72.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 41.33 112.524 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.49 -28.48 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 71.05 110.886 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.27 -96.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 41.35 112.455 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 73.31 112.516 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.338 . . . . 63.41 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.16 72.9 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.139 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.33 -12.42 35.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.861 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.79 -12.39 27.95 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 63.31 112.478 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.452 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 4.4 p-90 -69.04 -38.94 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 54.23 110.907 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -71.27 -22.3 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.893 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -60.7 -83.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.868 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -96.63 -77.64 0.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.35 110.908 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 69.6 m -105.58 131.61 21.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.621 0.724 . . . . 55.34 110.887 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.76 -8.41 23.53 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.672 2.248 . . . . 73.41 112.359 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -76.19 -4.28 40.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 61.31 110.929 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.6 55.55 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.865 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.56 -30.74 39.14 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 72.13 112.453 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -63.54 -75.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 52.12 110.937 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.09 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 60.34 112.519 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.708 -0.758 . . . . 54.41 112.48 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.806 0.336 . . . . 43.44 111.147 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.684 ' HB1' ' CD1' ' A' ' 5' ' ' TRP . . . -94.98 63.4 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 64.34 111.118 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -53.77 54.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 62.02 110.868 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.09 -23.42 11.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 35.13 112.495 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.684 ' CD1' ' HB1' ' A' ' 2' ' ' ALA . 3.6 m95 -95.74 -32.03 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 72.5 110.951 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -46.12 -46.5 17.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.2 110.886 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -45.35 -56.8 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 73.33 110.872 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -90.47 -76.04 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 64.4 110.908 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 1.4 m -120.49 102.44 45.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.631 0.729 . . . . 73.45 110.917 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 9' ' ' CYS . 53.6 Cg_endo -69.81 -13.86 35.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 61.02 112.342 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -5.81 38.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.89 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -93.47 69.52 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 65.35 110.863 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 2' ' ' ALA . . . -74.36 58.85 2.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 73.11 112.519 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -101.86 -73.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 74.52 110.92 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.88 -112.19 3.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 65.34 112.47 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' N ' ' HE1' ' A' ' 5' ' ' TRP . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 63.21 112.481 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.848 0.356 . . . . 73.14 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.77 75.8 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.11 111.1 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -10.13 22.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.864 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.51 -11.82 4.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.799 -0.715 . . . . 40.51 112.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.6 m95 -37.12 -77.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.801 0.334 . . . . 73.03 110.887 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -66.16 -30.56 71.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.91 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 13.2 mtp180 -55.53 -78.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.9 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -96.61 -78.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.4 110.859 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -121.81 130.14 24.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.612 0.72 . . . . 73.25 110.947 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -4.96 15.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.258 . . . . 65.33 112.341 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.78 10.09 24.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.894 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.62 39.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 61.13 110.897 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.42 -21.63 57.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 61.32 112.463 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -31.98 72.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 44.25 110.852 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.68 -92.17 1.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 54.25 112.491 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 73.31 112.482 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.854 0.359 . . . . 74.52 111.106 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HB1' ' HE1' ' A' ' 5' ' ' TRP . . . -120.61 74.79 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 71.22 111.103 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -99.96 -16.84 17.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.41 110.856 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.37 -13.28 3.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.756 -0.735 . . . . 71.42 112.505 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.551 ' HE1' ' HB1' ' A' ' 2' ' ' ALA . 21.8 m95 -41.85 -76.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.812 0.339 . . . . 75.33 110.942 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -76.39 -14.92 60.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 71.21 110.896 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -79.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.55 110.865 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -93.06 -75.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.915 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.47 128.74 25.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.709 . . . . 62.3 110.87 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.5 Cg_endo -69.72 -5.31 15.89 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 74.15 112.376 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.55 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -110.96 10.49 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 61.05 110.937 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -94.44 63.46 2.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 64.12 110.866 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.61 20.43 41.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 75.31 112.456 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 -19.69 8.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 64.31 110.883 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.18 -76.44 0.58 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 53.24 112.46 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 64.53 112.472 -179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.847 0.356 . . . . 75.31 111.097 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 5' ' ' TRP . . . -120.88 75.73 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 64.5 111.087 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -9.84 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.54 110.878 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 7' ' ' ARG . . . -55.38 -12.07 4.15 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 50.41 112.536 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 2' ' ' ALA . 16.8 m95 -36.56 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 61.13 110.943 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -30.76 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.899 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.529 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.4 mtp180 -55.26 -78.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.877 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -96.59 -78.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 64.44 110.865 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.9 130.12 24.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.623 0.725 . . . . 74.43 110.898 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 53.4 Cg_endo -69.82 -4.5 14.19 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.667 2.245 . . . . 73.15 112.282 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 11' ' ' LEU . 1.9 pp -104.69 3.52 31.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 74.12 110.961 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -88.84 60.87 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.899 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.97 6.05 76.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 64.3 112.508 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -29.82 11.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 70.3 110.881 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.89 -89.11 1.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.13 112.477 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 75.13 112.466 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.846 0.355 . . . . 74.01 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.32 59.68 0.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 73.32 111.099 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -12.57 58.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.866 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.95 -12.98 17.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 72.51 112.452 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' CYS . 3.7 p-90 -70.23 -37.49 75.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.881 0.372 . . . . 71.4 110.931 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -18.19 61.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 64.34 110.884 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -65.28 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 64.44 110.884 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 -77.64 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.878 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 18.8 p -104.45 130.73 22.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 71.45 110.831 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 -9.91 27.26 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.699 2.266 . . . . 74.33 112.318 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.13 -4.02 36.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 71.41 110.939 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 56.34 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 75.15 110.907 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.17 27.0 11.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 72.13 112.527 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.12 -68.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.338 . . . . 71.53 110.859 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.92 -103.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 73.04 112.475 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 70.45 112.451 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.807 0.337 . . . . 61.21 111.099 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.75 51.29 2.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 43.25 111.068 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -13.62 42.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 74.13 110.878 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.6 -19.03 17.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.717 -0.754 . . . . 44.42 112.513 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -80.11 -17.66 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.871 0.367 . . . . 62.53 110.969 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 47.0 mmtt -78.41 -14.76 59.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.904 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -85.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 74.15 110.851 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -80.2 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 64.45 110.932 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -53.55 109.12 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 71.5 110.931 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.645 ' HG2' HD23 ' A' ' 11' ' ' LEU . 53.5 Cg_endo -69.78 -12.74 33.47 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.663 2.242 . . . . 61.42 112.336 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -121.12 25.54 9.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.922 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.01 4.56 14.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 72.21 110.886 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -47.91 -30.13 6.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 42.1 112.486 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -40.8 95.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 62.23 110.895 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.83 -96.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 63.52 112.474 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 72.22 112.499 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.808 0.337 . . . . 51.21 111.13 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' HA2' ' A' ' 16' ' ' GLY . . . -95.86 54.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 70.55 111.131 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -13.87 42.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.826 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.51 -19.42 18.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 60.22 112.49 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.457 ' CD1' ' HG2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -76.8 -14.09 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 61.2 110.935 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HG2' ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -86.54 -14.04 44.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.892 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -78.92 -82.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 70.32 110.876 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.25 -80.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.883 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 20.2 m -62.45 112.19 6.06 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.602 0.715 . . . . 64.45 110.894 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.556 ' HG2' HD23 ' A' ' 11' ' ' LEU . 54.4 Cg_endo -69.72 -10.54 28.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.688 2.259 . . . . 62.35 112.368 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -120.51 25.03 10.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.914 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -80.08 8.25 7.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 71.44 110.848 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.06 -29.4 8.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.5 87.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 61.11 110.916 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.39 -92.38 1.82 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 54.31 112.475 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' ' HB1' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 64.01 112.525 -179.892 . . . . . . . . 1 1 . 1 stop_ save_